You are currently viewing a new version of our website. To view the old version click .
Pharmaceuticals
  • Correction
  • Open Access

14 January 2025

Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953

,
,
,
,
,
,
,
,
and
1
Department of Pharmacology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt
2
Department of Family Medicine, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
3
Department of Child Health, College of Medicine, University of Bisha, Bisha 61922, Saudi Arabia
4
Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
This article belongs to the Special Issue Drug Treatments for Inflammatory Bowel Diseases
Text Correction
There was an error in the original publication [1]. Due to errors in the nomenclature of the tested drug by several suppliers, BD-AcAc2 was mistakenly referred to as (R,R)-BD-AcAc2, which is (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate ketone ester with the formula C8H16O4. The correct nomenclature, however, is (R,S)-BD-AcAc2, which is R,S-1,3-Butanediol acetoacetate diester with the formula C12H18O6. Accordingly, BD-AcAc2 should be referred to as (R,S)-BD-AcAc2 throughout the manuscript, including in the title, keywords, and abbreviations.
A correction has been made to the Materials and Methods, Drugs and Chemicals, first sentence in paragraph 1:
BD-AcAc2, which is R,S-1,3-Butanediol acetoacetate diester with the formula C12H18O6, was obtained from MCE (Monmouth Junction, NJ, USA).
In the abbreviations section, “BD-AcAc2, (R)-3-Hydroxybutyl (R)-3-hydroxybutyrate ketone ester” was corrected as “BD-AcAc2, butanediol acetoacetate diester”.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Saber, S.; Alamri, M.M.S.; Alfaifi, J.; Saleh, L.A.; Abdel-Ghany, S.; Aboregela, A.M.; Farrag, A.A.; Almaeen, A.H.; Adam, M.I.E.; AlQahtani, A.A.J.; et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.